Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children
Withdrawn before enrolling
Conditions studied: Non-Alcoholic Steatohepatitis
In brief
The purpose of this study is to document how often specific genotypes known to be associated with adult-onset NASH (Non-Alcoholic Steatohepatitis) occur in a pediatric cohort and investigate whether these genotypes are associated with increased susceptibility to NASH.
Key facts
- Study ID
- NCT00677183
- Run by
- Medical College of Wisconsin
- People needed
- 0
- Starts
- 2008-05-01
- Expected to finish
- 2016-05-01
- Last updated by the study team
- 2015-08-25
Who can join
Age: 2 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All subjects aged 2-18 with biopsy proven NAFLD and/or NASH undergoing a blood draw and willing to consent to this study will qualify for inclusion in this protocol.
You may not qualify if…
- other causes of chronic liver disease or other chronic diseases, specifically autoimmune disorders, immunodeficiencies, or individuals with congenital/genetic disorders
- chronic viral hepatitis, Wilson's disease, or alpha -1- antitrypsin deficiency
- acute life threatening illness or conditions
Where it is running
- Children's Hospital of Wisconsin — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.